Annora Pharma Private Limited FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Mar 28, 2025
  • No warning letters matched by name
Inspections 4 0 OAI
Recalls 2 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Annora Pharma Private Limited has 2 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Annora Pharma Private Limited" is on file.

What these totals cover: FDA records filed under the name "Annora Pharma Private Limited".

Latest recall
D-0626-2026 · Class II · Jun 4, 2026
Latest inspection
Mar 28, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls2Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Annora Pharma Private Limited's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Annora Pharma Private Limited: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600020
202520000
202400000
202300000
202200000
202100000
202000000
201910000
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Annora Pharma Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Annora Pharma Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

2 recall records from Feb 3, 2026 to Jun 4, 2026.

NumberClassProductDate
D-0626-2026Class IILacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd…Jun 4, 2026
D-0391-2026Class IIIPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx…Feb 3, 2026

Recent FDA inspections

4 inspections from Nov 10, 2018 to Mar 28, 2025.

DateSiteProductClassificationFEI
Mar 28, 2025Hyderabad, IndiaDrugsVoluntary Action Indicated (VAI)3013944676
Mar 13, 2025Hyderabad, IndiaDrugsNo Action Indicated (NAI)3013944676
Sep 13, 2019Hyderabad, IndiaDrugsNo Action Indicated (NAI)3013944676
Nov 10, 2018Hyderabad, IndiaDrugsNo Action Indicated (NAI)3013944676
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3013944676Hyderabad, India4Mar 28, 2025

Annora Pharma Private Limited and the FDA: common questions

Has Annora Pharma Private Limited received an FDA warning letter?

No FDA warning letter addressed to the name "Annora Pharma Private Limited" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Annora Pharma Private Limited received an FDA Form 483?

FDA has not published a Form 483 for "Annora Pharma Private Limited" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Annora Pharma Private Limited?

The most recent FDA inspection on file ended Mar 28, 2025 at Hyderabad, India and was classified VAI. FDA has 4 inspections of Annora Pharma Private Limited on file.

Has Annora Pharma Private Limited had an FDA recall?

Yes. Annora Pharma Private Limited has 2 FDA recalls on record. The most recent started Jun 4, 2026.

Need more than this page shows? Ask about Annora Pharma Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.